Pexelizumab

pexelizumab · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Pexelizumab, covering 2017-02-23 to 2023-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) [Phase 3]